Glucose Transporter Type 1 Deficiency Syndrome (Glut1 DS)
3 clinical trials · Condition
◉ Watch Glucose Transporter Type 1 Deficiency Syndrome (Glut1 DS)
| Record | Firm | Date |
|---|---|---|
| Crossover Study to Assess the Efficacy and Safety of UX007 in the Treatment of Movement Disorders Associated With Glucose Transporter Type 1 Deficiency Syndrome (Glut1 DS) (NCT02960217) | Ultragenyx Pharmaceutical Inc | 2017-04-19 |
| Phase 2 Study of Triheptanoin (UX007) for the Treatment of Glucose Transporter Type 1 Deficiency Syndrome (Glut1 DS) (NCT01993186) | Ultragenyx Pharmaceutical Inc | 2014-02-28 |
| An Open-Label Trial of Triheptanoin in Patients With Glucose Transporter Type-1 Deficiency Syndrome (NCT02036853) | Adrian Lacy | 2014-02-20 |
Track Glucose Transporter Type 1 Deficiency Syndrome (Glut1 DS) automatically
Every clearance here is in the API, with alerts when new ones post.